Talk:David A. Sinclair

This is the talk page for discussing improvements to the David A. Sinclair article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.

If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

Biography: Science and Academia

	Biography portal This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles
	This article is supported by the science and academia work group.

Australia C‑class Low‑importance

	Australia portal David A. Sinclair is within the scope of WikiProject Australia, which aims to improve Wikipedia's coverage of Australia and Australia-related topics. If you would like to participate, visit the project page.AustraliaWikipedia:WikiProject AustraliaTemplate:WikiProject AustraliaAustralia articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Low	This article has been rated as Low-importance on the project's importance scale.
	Need help improving this article? Ask a Librarian^{What's this?} at the National Library of Australia.
	The Wikimedia Australia chapter can be contacted via email to helpwikimedia.org.au for non-editorial assistance.

Medicine C‑class Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Low	This article has been rated as Low-importance on the project's importance scale.

Skepticism C‑class Low‑importance

	This article is within the scope of WikiProject Skepticism, a collaborative effort to improve the coverage of science, pseudoscience, pseudohistory and skepticism related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SkepticismWikipedia:WikiProject SkepticismTemplate:WikiProject SkepticismSkepticism articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Low	This article has been rated as Low-importance on the project's importance scale.

Transhumanism Low‑importance

David A. Sinclair' is part of WikiProject Transhumanism, which aims to organize, expand, clean up, and guide Transhumanism related articles on Wikipedia. If you would like to participate, you can edit this article, or visit the project page for more details.TranshumanismWikipedia:WikiProject TranshumanismTemplate:WikiProject TranshumanismTranshumanism articles

Low

This article has been rated as Low-importance on the project's importance scale.

For more information and how you can help click Show:

If you would like to participate, you can edit this article, or visit the project page for more details.

Quick help:

See changes to:

To Do List:

edit - history - watch - purge

Join WikiProject transhumanism and be bold

Show off a userbox with {{userWPA}} or {{userWPA2}} and attract potential members
Help with articles.
See this month's adopt an article.
Help out with the To-do lists

Be consistent

Use a "standard" layout for transhumanism related articles (see: The perfect article, and Featured articles)
Add Transhumanism navigation template on the bottom of all transhumanism articles; (use {{Transhumanism}} or see navigation template)
Add Transhumanism info box to all transhumanism related talk pages (use {{Wpa}} or see info box)
Add [[Category:transhumanism]] to the bottom of all transhumanism related articles, so it shows up on the list of transhumanism articles

Maintenance / Etc

Find/cite sources for all positions of an article (see citing sources.
Try to expand stubs, however, some "new" articles may be neologisms, as this is common with positions on theories on life and may be suitable for deletion (see deletion process)
Watch the list of transhumanism related articles and add to accordingly (see transhumanism articles)
And always write for an encyclopedia.

Create

Notable transhumanist articles

Shorten / merge into others

Expand

a transhumanism stub

Your immediate attention

false choice into false dilemma - discuss whether you are for or against this merge here
Clarify references in Transhumanism, using footnotes.

United States: Massachusetts / Boston Low‑importance

	United States portal This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States articles
Low	This article has been rated as Low-importance on the project's importance scale.
	Massachusetts portal This article is supported by WikiProject Massachusetts (assessed as Low-importance).
	Massachusetts portal This article is supported by WikiProject Massachusetts - Boston (assessed as Mid-importance).

On 23 March 2021, it was proposed that this article be moved from David Andrew Sinclair to David A. Sinclair. The result of the discussion was moved.

Pretty lush[edit]

I don't know why, but I get the feeling that a friend of this person wrote the article. Or at least a fan. It reads like a eulogy, which is ironic because so much of his research has to do with avoiding that sort of thing. Maybe resume is a better analogy. Anyhow, I'm putting up a resume-style template message. Rhetth (talk) 03:29, 5 January 2009 (UTC)[reply]

lush alright and it's been edited by a wikipedian named davidasinclair and another one named editorboxofnumbers that know a whole lot about davidasinclair Havadmed (talk) 03:29, 16 April 2024 (UTC)[reply]

Any critique of his work can absolutely be included so long as it is in WP:RS. In fact, use of secondary independent sources is expected, rather than citing David's own primary source work. Zenomonoz (talk) 03:58, 16 April 2024 (UTC)[reply]

Mail[edit]

Hi from Germany Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@... Datum: 22.12.2013 00:25 Hi Alia, Im David SInclair, age 44, born sydney Australia. Here is my CV. School was St. Ives High School, Sydney. Married, 3 children. Thanks, David --Alia 2005 (talk) 01:30, 22 December 2013 (UTC)[reply]

new Mail:

Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@..." Datum: 22.12.2013 13:03 1969, June 26th. Danke --Alia 2005 (talk) 13:04, 24 December 2013 (UTC)[reply]

Professor[edit]

New Mail Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@..." Datum: 25.12.2013 01:29 Thank you Alia! I obtained Bachelor of Science (BSc) with First Class honors at the University of New South Wales (UNSW), Sydney, Australia. Ph.D. in Biochemistry and Molecular genetics. Ph.D. = Doctor of Philosophy Yes I am a tenured professor in the Genetics Depertment of Harvard Medical School (HMS), Boston, Massachusetts Im also a co-joint Professor at the University of New South Wales (UNSW), Sydney, Australia. David Sinclair is a scientist and entrepreneur working on increasing human health, productivity, and lifespan. After co-discovering a molecular cause of aging at the Massachusetts Institute in Boston in the mid-1990s in the Laboratory of Leonard Guarente, he joined the faculty of Harvard Medical School at the age of 29 as one of their youngest faculty members, where is now a full tenured professor in the Genetics Department. In 2005, he founded the Glenn Laboratories for Aging Research and serves as their Co-Director. He co-founded the Journal Aging in 2009. He is also a Professor at the Lowy Cancer Center at the University of New South Wales in the Department of Pharmacology. His main line of research is aimed at understanding why we grow old and on using this knowledge to prevent and treat both rare and common diseases. His is perhaps best known for identifying resveratrol from red wine as an anti-aging molecule. He has founded five biotechnology companies to treat diseases (Sirtris, NASDAQ: SIRT), improve female reproductive health and IVF (OvaScience, NASDAQ: OVAS), treat type 2 diabetes (Cohbar), to develop vaccines against malaria, chlamydia, tuberculosis, pneumonia, and cancer (Genocea), and to reverse aging and age-related diseases (MetroBiotech). He spoke at TEDx and TEDMED events in 2008 and 2012. He has received numerous awards including The Australian Commonwealth Prize, the Nathan Shock Award and a MERIT Awards from the National Institutes of Health, the Merck Prize, the Genzyme Outstanding Achievement in Biomedical Science Award, the Bio-Innovator award, and Cosmos’ magazine's Bright Sparks award for Top Scientists under 40. He is featured in numerous books including "The Yough Pill" by David Stipp and "Immortal Quest" by Leonard Guarente. A fictional story was written about his research and Merry Xmas, David --Alia 2005 (talk) 04:38, 25 December 2013 (UTC)[reply]

Sirtris update[edit]

The history of Sirtris ends with the acquisition by GlaxoSmithKline in 2008. It should be mentioned that GSK shut down Sirtris in 2013. http://www.xconomy.com/boston/2013/03/12/glaxosmithkline-shuts-down-sirtris-five-years-after-720m-buyout — Preceding unsigned comment added by 37.210.161.59 (talk) 19:08, 8 January 2017 (UTC)[reply]

Sinclair article is Terribly inadequate considering importance / public interest[edit]

It's more scrubbed for politeness than informative, much less controversial, good or bad. Is this because of a trend away from text generally? To my mind Wikipedia 'must' stand up as an authoritative source. Anyway, I can list some topics I'd like to see covered (IF I can get around this HORRIBLE ARCHAIC EDITOR):

Dr. Sinclair as showman
Rightful successor to Durk and Sandy's ideas?
How have Sinclairs ideas and claims aged?
What are other luminaries past and present saying about Sinclair?

--Xgenei (talk) 02:02, 20 September 2020 (UTC)[reply]

- How about other serious concerns, which may reflect on the claims in his "controversial" (at least!) books? See KHN.org ("A Fountain of Youth Pill? Sure, If You're A Mouse.") ELSchissel (talk) 14:45, 2 December 2020 (UTC)[reply]
  agree. and in fact someone tried to provide balance to the resveratrol claims and their stuff got reverted 116.84.110.196 (talk) 04:40, 1 May 2022 (UTC)[reply]

Reason for change to short description (Australian biogerontologist --> Australian geneticist)[edit]

There are no notable sources that I could find that call Sinclair a biogerontologist. However, there are reliable sources such as [1][2][3][4] that refer to him as a geneticist. Also, he is a professor of genetics. While Sinclair is a biogerontologist, his work focuses more on the genetic aspects of aging; biogerontology includes more than just genetics. Therefore, it would be more fitting to describe him as a geneticist. Ajshul 😃 (talk) 13:29, 23 March 2021 (UTC)[reply]

Requested move 23 March 2021[edit]

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: moved. (non-admin closure) ~ Aseleste (t, e | c, l) 15:58, 30 March 2021 (UTC)[reply]

David Andrew Sinclair → David A. Sinclair – In almost all sources, David Sinclair or David A. Sinclair is used to refer to the subject, never David Andrew Sinclair (See [5] [6] [7] and also his name as the author of his book). Currently, there is a redirect at David A. Sinclair, which originally redirected to this subject's page, but then changed to a redirect to a disambiguation page with two David A. Sinclair's, one of them being this subject, and the other being a subject with no article anymore. With only this David A. Sinclair currently on Wikipedia, and with David Andrew Sinclair never really being used to refer to the subject in any sources, per WP:NCBIO and more specifically, per WP:INITS, this page should be moved there. Ajshul 😃 (talk) 15:09, 23 March 2021 (UTC) Ajshul 😃 (talk) 15:22, 23 March 2021 (UTC)[reply]

Support per well-sourced nomination. Subject's WP:COMMONNAME is indeed David A. Sinclair, as depicted upon the cover of his book. —Roman Spinner (talk • contribs) 17:07, 23 March 2021 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.